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DogsAbstract Calcium oxalate crystalluria appears to be a common problem in most of small animal
clinics. This current study aimed at inducing a condition of oxalate crystalluria in beagles and
record the primary changes in canine blood and urine on response to oxalates injection. 15 dogs
were divided into two groups; those in the treatment group were injected intravenously with
0.5 M potassium oxalate and the dogs of control group were injected with physiological saline
for ﬁve successive days. Urine test revealed a signiﬁcant decrease in urinary creatinine and urinary
urea nitrogen levels. The ultrastructural examination of urine sediment showed typical and atypical
phases of calcium oxalate crystals and the X-ray defractionation of these crystals showed high con-
tent of calcium in addition to other minerals. Therefore potassium oxalate injection may provide an
example of calcium oxalate crystalluria which may answer some question around the pathogenesis
of this problem in dogs.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Veterinary Medicine, Cairo
University.1. Introduction
Urolithiasis is a recurrent clinical problem in dogs throughout
the world. Although struvite uroliths have been reported as the
most common uroliths worldwide [1,2], recent studies evalu-
ated the trends in stone submissions in the period of last ten
to twenty years and have revealed equalization of calciumoxalate and struvite-containing calculi, and subsequent in-
creases in calcium oxalate-containing uroliths thereafter [3].
The main reasons of the long-term changes in mineral compo-
sition of uroliths are yet unknown [4]. However, scientists
found out some predisposing factors which might incorporate
in stone formation. Some of these factors might include demo-
graphic and nutritional changes, preference to certain types of
breed, and complex interaction of other multiple factors [5].
The process of stone formation starts with precipitation of
crystals in when the urine is oversaturated with calcium oxa-
late, colloquially the urine where the ion product in excess of
the level at which spontaneous precipitation occurs. However,
urine contains inhibitor(s) that can withhold the process of
supersaturation. Most of this activity can be ascribed to
macromolecules and a considerable participation by citric acid
and some ions [6]. Magnesium can be considered to act as an
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its capacity as a chelator of oxalate. Magnesium oxalate is
more soluble than CaOx which enables oxalate excretion out-
side the urinary system. Although it has been reported that
magnesium could inhibit crystal nucleation [7], growth [8]
and aggregation [9], However, there is little evidence to recom-
mend magnesium therapy in patients with urolithiasis. Oxa-
lates are highly toxic agents to the renal tissue. They are
believed to play an infamous role in calcium oxalate urinary
stone formation [10] through induction of severe tubular in-
jury, cell sloughing [11], and renal insufﬁciency or renal failure
in some case. Moreover, oxalates may lead to changes of the
whole blood picture where Robinson [12] reported a signiﬁ-
cantly decreased hemoglobin, hematocrit, erythrocytes, and
neutrophilia in female rats after receiving 4% EG for 10 days.
In addition, severe anemia and acute renal failure were re-
corded in a patient with chronic exposure to both very large
doses of oxalate precursor [13].
After urinary supersaturation, the next step in stone
formation process is nucleation which means formation of a
solid crystal phase in a solution followed by retention of these
crystals within the renal tissue to act as nucleus to simply
permit further crystals deposition, growth and aggregation
[14]. Urinary macromolecules prevent the nucleation step by
binding within pre-formed crystals or adsorption on a crystal
surface to induce degradation and dissolution of crystals faces
and edges [15]. Only scanning electron microscopy (SEM) can
provide these information and record the completeness of uri-
nary inhibitors against crystallization. Furthermore SEM is
supplied by additional equipment for analysis of the crystals
and measure mineral and other elemental content.
In the current study we had exposed beagle dogs to potas-
sium oxalate injection in order to induce crystalluria. The aim
of this study is to assess the hematological and urinary changes
accompany the process of crystalluria in canines. We also
aimed at examining the ultrastructure and the chemical com-
positions of the biologically produced CaOx crystals after
frequent injection of oxalates.
2. Materials and methods
2.1. Animals
Fifteen healthy intact adult dogs (beagles and mongrel breeds)
aged between 2.5 and 4 years old were selected in this study.
Seven dogs (two males and ﬁve females) were assigned to the
control group, and the other eight dogs (four males and four
females) were considered the treatment group. Dogs were
housed in stainless net cages (1 dog per cage) with ten-day
quarantine and acclimatization periods in the department of
clinical veterinary medicine, Yangzhou University, Yangzhou
city, China. Dry mixed food was provided for dogs at twice
daily and tap-water was provided ad libitum.
2.2. Study design
0.5 M potassium oxalate solution (K2C2O4ÆH2O) was prepared
and sterilized by passing through a 0.22-lm ﬁlter. Animals in
the treatment group were given 0.5 M KOx at a dose of
0.13 ml/kg, while the same volumes of 0.9% physiological
saline were given to the control ones. The Dose was chosenaccording to [16]. Butterﬂy catheters were inserted into the
cephalic veins and ﬁxed. Each group was injected with the
assigned solutions three times a day for 5 consecutive days.
All experiments and procedures performed on the animals
were approved by the Animal Care and Use Committee of
Yangzhou University.
2.3. Hematological picture
Blood samples were collected just prior to injection, and on
days one, three and ﬁve. Five mL-blood samples were collected
each time from the cephalic veins of injected dogs. Two-
hundred microlitre of blood samples were added into tubes
along with EDTA. The whole blood was anti-coagulated by
adding EDTA and analyzed within 20 min by automatic blood
analyzers (BC-2800, Mindray biomedical electronics, China).
White blood cell (WBC) count, differential leukocyte, red
blood cell (RBC) count, hemoglobin (HGB) hematocrit
(HCT), and platelet count were measured.
2.4. Urine analyses
Urine samples were collected daily from day 0 till day 5 by
indwelling catheters. Every urine sample was divided into
two parts. One part was examined for urine pH immediately.
The other part was placed in a tube and stored at 20 C
for further biochemical analyses to determine the urinary
levels of calcium (Ca), magnesium (Mg), urea nitrogen
(UN), and creatinine (CR). The previous elements were ana-
lyzed by automatic biochemical analyser (AU 480, Backman,
USA).
2.5. Urine sediment examination
Five millilitre of urine were centrifuged at 6000g for 10 min;
the sediments were spread on a microscopical slide and exam-
ined by light microscopy. Sediment suspensions were dried
overnight at 37 C, mounted on aluminium stubs and coated
with gold 3-nm thickness using a gold sputter. The stubs were
examined using an S-4800; Hitachi SEM equipped with an
X-ray defractometer.
2.6. Statistical analyses
Mixed ANOVA using SPSS (Version 16.00) software was used
for statistical analysis. Time (Day 0, Day1, Day3 and Day5)
was used as a within-subject factor meanwhile the treatment
was used as a between-subject factor (Saline Vs Potassium oxa-
late). Bonferroni’s post hoc test was used to identify speciﬁc
differences. A Pearson correlation test was used to determine
the relationship between different urine parameters. The level
of signiﬁcance at which the null hypothesis was rejected was
a= 0.05. Values in the ﬁgures are means ± SE.3. Results
3.1. Hematological ﬁndings
The hematological parameters showed non-signiﬁcant differ-
ences (P> 0.05) between treatment and control groups.
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Statistical analysis indicated that both time (F3, 57 = 0.603,
P= 0.623) and treatment (F1, 58 = 0.448, P= 0.533) vari-
ables when work independently had non-signiﬁcant effects
on the urinary urea nitrogen. However, when they concur-
rently work, we observed that the (time X treatment) interac-
tion had a signiﬁcant effect (F3, 57 = 3.268, P= 0.03) where
the post hoc test showed that the treatment group showed
reduced levels of urinary urea nitrogen on D3 and D5 post
injection (pi) (Fig. 1A). Similarly time (F3, 57 = 2.81,
P= 0.071) and treatment (F1, 58 = 0.951, P= 0.374) effects
did not signiﬁcantly inﬂuence the urinary creatinine level but
the (time X treatment) interaction did (F3, 57 = 4.12,
P= 0.02) where the post hoc test showed that the dogs
showed reduced levels of creatinine on D5 (Fig. 1B). Finally,
urinary Mg and urinary Ca did not show any signiﬁcant
changes between saline and potassium-oxalate injected dogs.
Pearson correlation coefﬁcient showed a signiﬁcant correla-
tion between urea nitrogen and creatinine levels of urine
(r= 0.724, P= 0.01). There was a signiﬁcant correlation be-
tween urinary Mg and urinary urea nitrogen (r= 0.64,
P= 0.01), with creatinine (r = 0.51, P= 0.04) in control
group. There were not any signiﬁcant correlations between
urine parameters in potassium oxalate treated dogs. The mean
urine pH of the treatment group was about <6.7 and did not
express any signiﬁcant change compared to control group.Figure. 1 Urinary concentrations of urea nitrogen (A) and cr3.3. Urine sediment examination
Under light microscopy (LM): appearance of both types of cal-
cium oxalate dihydrate (COD), and calcium oxalate monohy-
drate (COM) crystals in different sizes in solitary or in
aggregation.
Under scanning electron microscopy (SEM): Isolated crys-
tals or clusters of CaOx crystals aggregation fused with some
tissue debris. Solitary tetrahedral shape of COD crystals and
adhered COD were observed under light microscope and
SEM. Atypical shapes of COM crystals were detected by
SEM as some COM crystals exhibited rounding at the edges,
bow–tie appearance. Some crystals appeared extensively
eroded and sub crystalline particles were detected. X-ray
defractionation of crystals revealed large content of Ca, Na,
Cl, K in addition to carbon and oxygen indicating for organic
matter (probably oxalate) and some cells of urinary sediment
contained calcium (Figs. 2 and 3).
4. Discussion
Oxalates are very toxic agents that have hazardous effects on
animal’s body. We designed this experiment to explore the
changes occurred in the hematology and urine parameters after
oxalate precursor injection for 5 consecutive days in beagle
dogs. We didn’t ﬁnd any signiﬁcant changes in the hematolog-
ical picture after oxalate injection. Our ﬁndings are similar toeatinine concentration (B) in control and treatment groups.
Figure. 2 Urinary sediment under scanning electron microscopy. (A) Tetrahedral calcium oxalate dihydrate crystals aggregation and
eroded surfaces. (B) X-ray defractionation results of crystals showing high content of Ca, Na, Cl and little content of K, Si.
Figure. 3 Calcium oxalate monohydrate under scanning electron microscopy. (A) Atypical calcium oxalate monohydrate crystals with
round edges and boa tie appearance. (B) X-ray defractionation results of crystals showing high content of Ca, Cl, Na, and little content of
K and Fe.
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picture were recorded.
Our results also showed signiﬁcant decreases in urinary lev-
els of creatinine and BUN as if they were retained inside the
body which suggests a disruption in the glomerular ﬁltration
due to the secondary effect oxalates changes in the renal phys-
iology. Although magnesium has been consistently reported to
inhibit CaOx crystal deposition in both inorganic solutions
and urine, but in the current experiment the measurements
of magnesium and calcium levels in urine did not show any sig-
niﬁcantly change throughout the experiment. These ﬁndings
are similar to the results in Stevenson in dogs [18] and Moc-
hizuki [19] in urolithiatic cats. Practically there is no convinc-
ing evidence that stone disease can be unequivocally ascribed
to a reduction in magnesium urinary output. Several studies
failed to detect any difference between stone forming patients
and healthy controls [20]. Although magnesium was signiﬁ-
cantly correlated to creatinine, BUN in urine of control group,but we did not ﬁnd any signiﬁcant correlations in the treatment
group between the urine parameters which might be because of
the decrease in the concentration levels of urinary UN and cre-
atinine but magnesium and calcium remained unchanged.
Kienyes secrete several substances including undifferenti-
ated proteins, and glycosaminoglycans that bound to the sur-
faces of COM crystals [21], incarcerated within them [22].
These substances are supposed to inhibit crystals retention
and nucleation by reducing the ability of attachment of
COM-more adherent phase-to renal epithelial cell membranes.
Therefore converting COM phase to a COD- less adherent
phase- is a mean of inhibiting crystals attachment and nucle-
ation [23]. The imperfect shapes of COM and COD crystals
observed under electron microscope were excreted by natural
urine which means that beside the mineral content, urine also
contains different proteins, lytic enzymes and other organic
matrix. These substances attack crystal faces and edges to in-
duce dissolution and degradation of the urinary crystals and
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instance osteopontin is incriminated in crystals erosion and the
appearance of cracked surfaces [24].
In addition, CaOx crystals themselves contain intracrystal-
line proteins, which create discontinuities within the mineral
phase, increase the nonuniform crystals and reduce the average
size of their crystallites component [25], in other meaning the
intracrystalline proteins that induce deformity and atypical
shape of the crystals. Grover [26] recorded massive erosions
and different degrees of crystals degradation of CaOx crystals
after incubation in MDCK containing crystals matrix extract
CME, while crystals incubated with cultured cells alone were
not eroded. In another way some crystals aggregated in amor-
phous shape together with tissue debris that might be due to
the THP urinary protein that may act as a glue which increases
the viscous binding between crystals and allow the crystals to
stick together in order to be expelled in urine [27]. High
content of K salts in the urine sediments might be due to the
overloading the circulation with potassium source through
the frequent injection of potassium oxalate.
5. Conclusion
CaOx urolithiasis in dogs is a growing problem of concern in
the veterinary ﬁeld. From this study we found that overloading
of oxalates into the canines body may change the urine param-
eters. We concluded that kidneys can defend against stone for-
mation by hindering the retention of oxalate crystals within the
renal tissue through excretion of natural urine which contains
potent inhibitors capable of degradation and dissolution of the
crystals. These ﬁndings assist in understanding the pathogene-
sis of the early events of urolithiasis in canines. Future research
may be directed toward analysis of the crystals matrix proteins
and measuring their concentration in canines’ urine by use of
high techniques to assess their role in inhibiting stone
formation.
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